BNGO compared with APVO: revenue, margins and what each company keeps, and the suppliers and customers both name

BNGOBionano Genomics, Inc.

Mkt capRevenueRevenue

APVOAptevo Therapeutics Inc.

Mkt capRevenueRevenue

Compare

BNGOBionano Genomics, Inc.

APVOAptevo Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

BNGO: latest quarter is a loss; flow not drawable. APVO: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BNGO 0

None

Shared 0

No disclosed counterparties: BNGO.

Only APVO 2

—Alligator Bioscience ABunlistedsupplier

—Open Monoclonal Technologyunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

BNGO, solidAPVO, dashed

BNGOBionano Genomics, Inc.

1.15▼−4.17%· post 1.18

Mkt cap$13.5MRevenue$8MQ2 FY26Revenue$29MFY25

APVOAptevo Therapeutics Inc.

1.31▼−3.68%· post 1.41

ClosedOct 30 '26

Mkt cap$2.4MRevenue—Revenue—

Compare

ClosedOct 30 '26

BNGOBionano Genomics, Inc.

APVOAptevo Therapeutics Inc.

1.15▼−4.17%post 1.18

Price

1.31▼−3.68%post 1.41

$13.5M

Mkt cap

$2.4M

Q2 FY26$8M

Revenue

—

FY25$29M

Revenue

—

BNGO1.15▼−4.17%vsAPVO1.31▼−3.68%ClosedOct 30 '26